Perfil e interacción de los usuarios con una app de salud digital para urolitiasis: estudio descriptivo de los primeros 699 usuarios

IF 1.2 4区医学 Q3 UROLOGY & NEPHROLOGY

Actas urologicas espanolas Pub Date : 2025-10-01 DOI:10.1016/j.acuro.2025.501819

J.A. Mainez , J.A. Galán , J.M. López , B. Isern-Amengual , P. Sanchís-Cortés

{"title":"Perfil e interacción de los usuarios con una app de salud digital para urolitiasis: estudio descriptivo de los primeros 699 usuarios","authors":"J.A. Mainez , J.A. Galán , J.M. López , B. Isern-Amengual , P. Sanchís-Cortés","doi":"10.1016/j.acuro.2025.501819","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Urolithiasis is a prevalent urological condition that requires continuous monitoring and management to prevent recurrence. The myLit-Control® App is a digital health tool designed to support self-management by tracking urinary pH, water intake, and medication adherence. This study aimed to describe the demographic and clinical characteristics of myLit-Control® App users in Spain, analyze their engagement patterns, and evaluate adherence to health goals.</div></div><div><h3>Patients and methods</h3><div>This retrospective observational study included users who downloaded the app between May 2022 and June 2024. Data on demographics, urinary pH tracking, water intake, and medication adherence were extracted and analyzed to explore correlations, group comparisons, and identify factors influencing adherence and outcomes.</div></div><div><h3>Results</h3><div>The study included 699 users, with a median age of 50 years (IQR: 40-59) and 57.1% male. A total of 217 users (31.0%) were taking urolithiasis-specific treatment. Urine pH monitoring was used by 52.9% of participants, with a rate of 53% (±37) within target pH levels. Water intake tracking was the most frequently used feature, yet adherence to hydration goals remained low (15±30%). A negative correlation was observed between age and treatment adherence (r=−0.456, p < 0.001).</div></div><div><h3>Conclusions</h3><div>The myLit-Control® App facilitates urinary pH monitoring and medication adherence, supporting self-management in urolithiasis patients. However, engagement with key features, particularly water intake tracking, remains suboptimal. Future research should explore long-term outcomes and strategies to enhance patient adherence, ensuring effective integration of mHealth tools in routine clinical practice.</div></div>","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"49 8","pages":"Article 501819"},"PeriodicalIF":1.2000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Actas urologicas espanolas","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0210480625001378","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction and objectives

Urolithiasis is a prevalent urological condition that requires continuous monitoring and management to prevent recurrence. The myLit-Control® App is a digital health tool designed to support self-management by tracking urinary pH, water intake, and medication adherence. This study aimed to describe the demographic and clinical characteristics of myLit-Control® App users in Spain, analyze their engagement patterns, and evaluate adherence to health goals.

Patients and methods

This retrospective observational study included users who downloaded the app between May 2022 and June 2024. Data on demographics, urinary pH tracking, water intake, and medication adherence were extracted and analyzed to explore correlations, group comparisons, and identify factors influencing adherence and outcomes.

Results

The study included 699 users, with a median age of 50 years (IQR: 40-59) and 57.1% male. A total of 217 users (31.0%) were taking urolithiasis-specific treatment. Urine pH monitoring was used by 52.9% of participants, with a rate of 53% (± 37) within target pH levels. Water intake tracking was the most frequently used feature, yet adherence to hydration goals remained low (15 ± 30%). A negative correlation was observed between age and treatment adherence (r = −0.456, p < 0.001).

Conclusions

The myLit-Control® App facilitates urinary pH monitoring and medication adherence, supporting self-management in urolithiasis patients. However, engagement with key features, particularly water intake tracking, remains suboptimal. Future research should explore long-term outcomes and strategies to enhance patient adherence, ensuring effective integration of mHealth tools in routine clinical practice.

Abstract Image

查看原文本刊更多论文

尿路石症数字健康应用程序的用户简介和用户互动：对前699名用户的描述性研究

前言和目的尿石症是一种常见的泌尿系统疾病，需要持续监测和管理以防止复发。myLit-Control®App是一款数字健康工具，旨在通过跟踪尿液pH值、饮水量和药物依从性来支持自我管理。本研究旨在描述西班牙myLit-Control®App用户的人口统计学和临床特征，分析他们的参与模式，并评估对健康目标的依从性。患者和方法这项回顾性观察研究包括在2022年5月至2024年6月期间下载该应用程序的用户。提取和分析人口统计学、尿pH值跟踪、饮水量和药物依从性的数据，以探索相关性、组比较，并确定影响依从性和结果的因素。结果本研究纳入699名用户，中位年龄50岁（IQR: 40-59），男性占57.1%。共有217名使用者（31.0%）正在接受尿石症特异性治疗。52.9%的参与者使用尿液pH监测，在目标pH水平内的比例为53%（±37）。水摄入量跟踪是最常用的功能，但坚持补水目标仍然很低（15±30%）。年龄与治疗依从性呈负相关（r = - 0.456, p < 0.001）。结论myLit-Control®应用程序促进尿pH监测和药物依从性，支持尿石症患者的自我管理。然而，与关键功能的互动，特别是水摄入跟踪，仍然不是最理想的。未来的研究应探索长期结果和策略，以提高患者的依从性，确保在常规临床实践中有效整合移动医疗工具。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Actas urologicas espanolas UROLOGY & NEPHROLOGY-

CiteScore

1.90

自引率

0.00%

发文量

审稿时长

46 days

期刊介绍： Actas Urológicas Españolas is an international journal dedicated to urological diseases and renal transplant. It has been the official publication of the Spanish Urology Association since 1974 and of the American Urology Confederation since 2008. Its articles cover all aspects related to urology. Actas Urológicas Españolas, governed by the peer review system (double blinded), is published online in Spanish and English. Consequently, manuscripts may be sent in Spanish or English and bidirectional free cost translation will be provided.